Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ukraine

European Innovation Council · Running

AIREST Multimodal Digital Biomarkers for Evidence-Based Mental Health Decision Support and Monitoring

Coordinator
Limited Liability Company Airest, Ukraine
Runs
1 June 2026 to 31 May 2028
Status
Running
EU funding
€495k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
101312962

What the project is doing

In the project's own words, from its summary on CORDIS.

AIREST (Artificial-Intelligence-based Rapid Emotional Screening Test) is an AI-driven Software as a Medical Device (SaMD) in development that uses modern AI and machine-learning methods to analyse multimodal behavioural biomarkers from short voice-and-video interactions. It combines acoustic and linguistic features of speech, vocal prosody, facial-expression dynamics and simple attention-related measures into objective, quantitative indicators of mental health.

The system is intended for early detection, standardised screening and diagnostic support for mental health conditions, including depressive episodes and recurrent depressive disorder, generalised anxiety disorder, mixed anxiety and depressive disorder and post-traumatic stress disorder (PTSD). By processing a few minutes of guided interaction, AIREST generates risk scores and trend indicators that can be integrated into existing clinical workflows and electronic health records.

Who is involved

OrganisationCityCountryRole
Limited Liability Company AirestKyivUkraineCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI